M2 EQUITYBITES-February 19, 2018-GSK receives European approval for expanded indication for Fluarix
M2 PHARMA-February 19, 2018-GSK receives European approval for expanded indication for Fluarix
is a trademarks of the GSK group of companies.
5 mL) Inactivated influenza vaccine, quadrivalent (IIV4), standard dose Fluarix
html), which includes the Fluarix
and FluLaval vaccines.
0 mL 90658 (multi-dose Q2035 (Medicare) vial) Fluarix
Four new, recently licensed vaccines are now available: FluMist Quadrivalent nasal LAIV (LAIV4) from Medlmmune for persons aged 2-49 years; Fluarix
Quadrivalent inactivated influenza vaccine (IIV4) from GlaxoSmithKline for those 3 years and older; Flucelvax, a cell culture-based inactivated influenza vaccine (ccIIV3) from Novartis for patients aged 18 years and older; and Flublok, a recombinant hemagglutinin vaccine from Protein Sciences for adults aged 18-49 years.
Four-strain versions are sold under the names Fluzone Quadrivalent, Fluarix
Quadrivalent and FluLaval Quadrivalent.
1) Also, studies done by the Food and Drug Administration (FDA) prior to release of the Fluarix
vaccine, as reported in the Physician's Desk Reference (PDR), show that 49.
GlaxoSmithKline will manufacture both the trivalent and quadrivalent forms of Fluarix
for next season, a company representative said.
GSK also believes distribution of its Fluarix
, another influenza vaccine, will follow in the next few weeks.